The diagnostic accuracy of tests for latent tuberculosis infection in hemodialysis patients: A systematic review and meta-analysis

Transplantation

Volumn 99, Issue 5, 2015, Pages 1084-1091

  Ferguson, Thomas W ^a,b   Tangri, Navdeep ^a,b   MacDonald, Kerry ^a,b   Hiebert, Brett ^a   Rigatto, Claudio ^b   Sood, Manish M ^c   Shaw, Souradet ^a   Lerner, Blake ^b   Xu, Yang ^b   Mahmud, Salaheddin ^a   Komenda, Paul ^b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b Seven Oaks General Hospital   (Canada)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; GOLD STANDARD; HEMODIALYSIS PATIENT; HUMAN; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; MEDICAL HISTORY; META ANALYSIS; MYCOBACTERIUM TUBERCULOSIS TEST KIT; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SEROLOGY TEST KIT; SYSTEMATIC REVIEW; THORAX RADIOGRAPHY; TUBERCULIN TEST; ADVERSE EFFECTS; RENAL REPLACEMENT THERAPY;

HUMANS; LATENT TUBERCULOSIS; RENAL DIALYSIS; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST;

EID: 84930378498     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000451     Document Type: Review

References (38)

1. Nuermberger E, Bishai WR, Grosset JH. Latent tuberculosis infection. Semin Respir Crit Care Med 2004;25:317.
2. Dheda K, Schwander SK, Zhu B, et al. The immunology of tuberculosis: from bench to bedside. Respirology 2010;15:433.
3. Girndt M, Sester U, Sester M, et al. Impaired cellular immune function in patients with end-stage renal failure. Nephrol Dial Transplant 1999;14:2807.
4. Passalent L, Khan K, Richardson R, et al. Detecting latent tuberculosis infection in hemodialysis patients: a head-to-head comparison of the T-SPOT.TB test, tuberculin skin test, and an expert physician panel. Clin J Am Soc Nephrol 2007;2:68.
5. Roshanravan B, Khatri M, Robinson-Cohen C, et al. A prospective study of frailty in nephrology-referred patients with CKD. Am J Kidney Dis 2012;60:912.
6. Richardson RM. The diagnosis of tuberculosis in dialysis patients. Semin Dial 2012;25:419.
7. Pai M, Riley LW, Colford JM Jr. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 2004;4:761.
8. Hoffmann M, Tsinalis D, Vernazza P, et al. Assessment of an Interferon-gamma release assay for the diagnosis of latent tuberculosis infection in haemodialysis patient. Swiss Med Wkly 2010;140:286.
9. Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Int J Surg 2011;9:672.
10. Ates G, Yildiz T, Danis R, et al. Incidence of tuberculosis disease and latent tuberculosis infection in patients with end stage renal disease in an endemic region. Ren Fail 2010;32:91.
11. Chung WK, Zheng ZL, Sung JY, et al. Validity of interferon-gamma-release assays for the diagnosis of latent tuberculosis in haemodialysis patients. Clin Microbiol Infect 2010;16:960.
12. Habesoglu MA, Torun D, Demiroglu YZ, et al. Value of the tuberculin skin test in screening for tuberculosis in dialysis patients. Transplant Proc 2007;39:883.
13. Centers for Disease Control and Prevention (CDC). Tuberculosis transmission in a renal dialysis center-Nevada. MMWR Morb Mortal Wkly Rep 2003: 2004;53:873.
14. Poduval RD, Hammes MS. Tuberculosis screening in dialysis patients-is the tuberculin test effective? Clin Nephrol 2003;59:436.
15. Seyhan EC, Sokucu S, Altin S, et al. Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection in hemodialysis patients. Transplant Infectious Disease 2010;12:98.
16. Triverio P, Bridevaux P, Roux-Lombard P, et al. Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients. Nephrol Dial Transplant 2009;24:1952.
17. Wauters A, Peetermans WE, Van den BP, et al. The value oftuberculin skin testing in haemodialysis patients. Nephrol Dial Transplant 2004;19:433.
18. Winthrop KL, Nyendak M, Calvet H, et al. Interferon-gamma release assays for diagnosing mycobacterium tuberculosis infection in renal dialysis patients. Clin J Am Soc Nephrol 2008;3:1357.
19. Linquist JA, Rosaia CM, Riemer B, etal. Tuberculosis exposure of patients and staff in an outpatient hemodialysis unit. Am J Infect Control 2002;30:307.
20. Anibarro L, Trigo M, Feijoo D, et al. Value of the tuberculin skin testing and of an interferon-gamma release assay in haemodialysis patients after exposure to M. tuberculosis. BMC Infect Dis 2012;12:195.
21. Ates G, Ozekinci T, Yildiz T, etal. Comparison ofinterferon-gamma release assay versus tuberculin skin test for latent tuberculosis screening in hemodialysis patients. Biotechnol Biotechnol Equip 2009;23:1242.
22. Chung WK, Zheng ZL, Kim H, et al. Serial testing of interferon-γ-release assays for the diagnosis of latent tuberculosis in hemodialysis patients. J Infect 2010;61:144.
23. Inoue T, Nakamura T, Katsuma A, et al. The value of QuantiFERON TB-Gold in the diagnosis of tuberculosis among dialysis patients. Nephrol Dial Transplant 2009;24:2252.
24. Lee SSJ, Chou KJ, Su IJ, et al. High prevalence of latent tuberculosis infection in patients in end-stage renal disease on hemodialysis: comparison of quantiFERON-TB GOLD, ELISPOT, and tuberculin skin test. Infection 2009;37:96.
25. Lee SS, Chou KJ, Dou HY, et al. High prevalence of latent tuberculosis infection in dialysis patients using the interferon-gamma release assay and tuberculin skin test. Clin J Am Soc Nephrol 2010;5:1451.
26. Kunst H, Khan KS. Age-related risk of hepatotoxicity in the treatment of latent tuberculosis infection: a systematic review. Int J Tuberc Lung Dis 2010;14:1374.
27. Rogerson TE, Chen S, Kok J, et al. Tests for latent tuberculosis in people with ESRD: a systematic review. Am J Kidney Dis 2013;61:33.
28. Tuberculosis Prevention and Control, Public Health Agency of Canada, Canadian Lung Association. Canadian Tuberculosis Standards. 6th ed. Canada: Minister of Health, 2007: 438.
29. Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009;9Suppl 3:S1.
30. Chadban SJ, Barraclough KA, Campbell SB, et al. KHA-CARI guideline: KHA-CARI adaptation of the KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients. Nephrology (Carlton) 2012;17:204.
31. Chia S, Karim M, Elwood RK, et al. Risk of tuberculosisin dialysis patients: a population-based study. Int J Tuberc Lung Dis 1998;2:989.
32. Bronfenbrenner M. Notes on the elasticity of derived demand. Oxford Economic Papers 1961;13:254.
33. Kowada A. Cost effectiveness of the interferon-gamma release assay for tuberculosis screening of hemodialysis patients. Nephrol Dial Transplant 2013;28:682.
34. Whiting P, Rutjes AW, Reitsma JB, et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003;3:25.
35. World Health Organization. Global Tuberculosis Report 2012. France: World Health Organization, 2012: 89.
36. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003;327:557.
37. Menke J. Bivariate random-effects meta-analysis of sensitivity and specificity with SAS PROC GLIMMIX. Methods Inf Med 2010;49:54.
38. Boyles A, Harris S, Rooney A, et al. Forest Plot Viewer: a new graphing tool. Epidemiology 2011;22:746.